Chemoinformaics analysis of (5-METHYL-2-PROP-1-EN-2-YLHEX-4-ENYL) ACETATE
| Molecular Weight | 196.29 | nRot | 5 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
| Exact Molecular Weight | 196.146 | nRing | 0 |
| Solubility: LogS | -6.066 | nHRing | 0 |
| Solubility: LogP | 6.263 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.9799 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.282 |
| Synth | 1.955 |
| Natural Product Likeliness | 0.416 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.009 |
| HIA | 0.002 |
| CACO-2 | -4.718 |
| MDCK | 0.0000237 |
| BBB | 0.672 |
| PPB | 0.972611 |
| VDSS | 1.093 |
| FU | 0.0240331 |
| CYP1A2-inh | 0.836 |
| CYP1A2-sub | 0.195 |
| CYP2c19-inh | 0.562 |
| CYP2c19-sub | 0.104 |
| CYP2c9-inh | 0.377 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.069 |
| CYP2d6-sub | 0.068 |
| CYP3a4-inh | 0.377 |
| CYP3a4-sub | 0.09 |
| CL | 4.881 |
| T12 | 0.229 |
| hERG | 0.056 |
| Ames | 0.007 |
| ROA | 0.034 |
| SkinSen | 0.96 |
| Carcinogencity | 0.2 |
| EI | 0.976 |
| Respiratory | 0.61 |
| NR-Aromatase | 0.259 |
| Antiviral | No |
| Prediction | 0.667874 |